Giovanni Caforio
Giovanni Caforio is the former CEO of Bristol-Myers Squibb and has recently taken on the role of CEO at Novartis. With extensive experience in the pharmaceutical industry and a strong understanding of both the American and European markets, Caforio is poised to lead Novartis into its next phase of growth. His appointment comes at a crucial time as the company navigates challenges in the healthcare landscape and aims to strengthen its market position.
Not in the pool (under ¢1).
Recent news mentions
Giovanni Caforio is the new president of Novartis and has made the list of the richest individuals.
«Bilanz»-Liste Reichste 2025: Prominente Manager neu dabei
Switzerland· 2025-11-28
Giovanni Caforio is the new chairman of the board under whom Vasant Narasimhan works.
Der Novartis-Chef fordert höhere Preise für Medikamente in EuropaSwitzerland· 2025-09-20
Giovanni Caforio has been elected as the chairman of Novartis, and expectations are high for his leadership.
«Novartis hat noch viel Spielraum zur Steigerung der Margen»Switzerland· 2025-04-04
Giovanni Caforio was elected as the new chairman of the board with over 98 percent of the votes.
Das Lohnpaket für den CEO erntet an der Generalversammlung KritikSwitzerland· 2025-03-07
Giovanni Caforio is the designated successor to Jörg Reinhardt at Novartis.
«In den USA liegt der CEO-Lohn im unteren Bereich»Switzerland· 2025-03-06
